Brian DeRubertis, MD, FACS

Chief of the Division of Vascular & Endovascular Surgery at New York Presbyterian-Weill Cornell Medicine

[Vascular News @VascularNews]

#VIVA24: Along with Lorenzo Patrone who is still in transit to Las Vegas, @sternvascular receives the 2024 VCA Award from @VIVAPhysicians. The accolade is given to young physician-leaders for vascular career advancement.

[The VIVA Foundation @VIVAPhysicians]

Register now: https://t.co/uTFYCQEhgd

[Abbott Cardiovascular @AbbottCardio]

The first patient has been successfully treated with our Esprit BTK Everolimus Eluting Resorbable Scaffold System, pioneering a new standard of care in BTK treatment.

Thanks @PK_MountSinai and team for your commitment to your patients.

Safety Info: https://t.co/twivNLQTJC

[Jason Belzer @belzerj]

We followed a great morning with a wonderful afternoon watching the first Esprit BTK commercial case at Columbia performed by @sahilparikhmd @AbbottCardio #ProudtobeAbbott

[Jason Belzer @belzerj]

Spending the morning with @derubertisMD observing the first commercial Esprit BTK case at Cornell is a great way to start the day. We are excited about what this therapy is bringing to patients. @AbbottCardio #ProudtobeAbbott

[Brian DeRubertis, MD, FACS @derubertisMD]

@UCIVascularSurg @Kabutey_MD @IsabellaKuoMD @SamuelChenMD @chauvascular @RMFujitaniMD @UCIrvineSurgery @UCIrvineSOM Congratulations!!!

[Endovascular Today @EVToday]

Abbott Begins LIFE-BTK Trial to Evaluate Esprit BTK Drug-Eluting Resorbable Scaffold to Treat CLI | @AbbottNews

https://t.co/uAhmG8eA14

[Brian DeRubertis, MD, FACS @derubertisMD]

Important time for patients suffering the threat of limb loss. Looking forward to the exciting work we have ahead of us in helping to evaluate this technology for our patients. @RamonVarcoeMD @sahilparikhmd

[Abbott Cardiovascular @AbbottCardio]

Breaking at #VEITH2019: Announcing the LIFE-BTK pivotal IDE clinical trial to evaluate the safety & effectiveness of ESPRIT BTK, a new everolimus eluting bioresorbable scaffold intended for treating critical limb ischemia!

Read about the #innovativetech:
https://t.co/dPOl4xhRvx